Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China flag China · Delayed Price · Currency is CNY
15.88
-0.26 (-1.61%)
At close: Feb 13, 2026

SHA:605077 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
942.08434.212,1281,0401,244248.78
Short-Term Investments
-583.66461.79387.5--
Trading Asset Securities
260.020.030.180.2270.05-
Cash & Short-Term Investments
1,2021,0182,5901,4281,314248.78
Cash Growth
168.74%-60.70%81.38%8.72%427.99%41.99%
Accounts Receivable
735.46769.01500.31392.94242.55173.6
Other Receivables
11.8526.76.058.1414.589.5
Receivables
747.31795.71506.37401.08257.13183.1
Inventory
640.99697.39282.04279.06199.74151.41
Other Current Assets
668.964.2136.1629.8732.2316
Total Current Assets
3,2592,5753,4152,1381,803599.3
Property, Plant & Equipment
3,7063,5881,8441,355991.3704.18
Long-Term Investments
75.7793.4994.42122.5358.5653.46
Goodwill
346.16346.16346.1626.1126.11-
Other Intangible Assets
299.71305.87282.65242.4690.0655.19
Long-Term Deferred Tax Assets
30.2523.538.133.957.37-
Long-Term Deferred Charges
31.4335.1317.2911.1412.5411.4
Other Long-Term Assets
13.324.89169.795.6215.46.15
Total Assets
7,7616,9926,1783,9053,0041,430
Accounts Payable
923.73443.34208.42169.9228.07194.99
Accrued Expenses
45.07122.6488.5571.2441.3735.98
Short-Term Debt
691.9150.3247.12260.24119.82102.75
Current Portion of Long-Term Debt
209.39226.64171.6539.74--
Current Portion of Leases
-0.950.561.24--
Current Income Taxes Payable
42.6837.132.34--20.86
Current Unearned Revenue
31.1415.0119.9512.058.587.45
Other Current Liabilities
174.28677.18253.16215.1257.8817.33
Total Current Liabilities
2,1181,6731,022769.53455.72379.37
Long-Term Debt
2,1881,8591,868345.4620.0251.17
Long-Term Leases
8.013.20.020.511.46-
Long-Term Unearned Revenue
149.12118.2894.2151.3738.425.26
Long-Term Deferred Tax Liabilities
77.6582.6292.1974.3753.9533.85
Other Long-Term Liabilities
---8-0.5
Total Liabilities
4,5413,7373,0771,249569.56490.16
Common Stock
303.05305.88234.61228.46163.1887.42
Additional Paid-In Capital
1,4241,4411,4791,4051,470170.98
Retained Earnings
1,3191,3631,2571,023801.28681.13
Treasury Stock
-36.1-61.99-77.37---
Comprehensive Income & Other
196.07196.13196.23-0.01-0.02-0.01
Total Common Equity
3,2063,2433,0892,6562,434939.52
Minority Interest
14.111.8911.59---
Shareholders' Equity
3,2203,2553,1012,6562,434939.52
Total Liabilities & Equity
7,7616,9926,1783,9053,0041,430
Total Debt
3,0972,2412,288647.18141.3153.92
Net Cash (Debt)
-1,895-1,223302.51780.961,17294.87
Net Cash Growth
---61.26%-33.38%1135.67%1278.18%
Net Cash Per Share
-5.86-3.231.022.634.080.43
Filing Date Shares Outstanding
291.97299.43296.99296.99296.99296.99
Total Common Shares Outstanding
291.97299.43296.99296.99296.99222.75
Working Capital
1,141902.052,3931,3691,347219.93
Book Value Per Share
10.3110.189.748.948.204.22
Tangible Book Value
2,5602,5912,4612,3872,318884.33
Tangible Book Value Per Share
8.108.007.628.047.813.97
Buildings
-1,014576.89429.74336.07250.13
Machinery
-2,2621,8031,429960.55789.18
Construction In Progress
-1,330290.58110.27230.9860.1
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.